MB-CTIH@EC2611A

CPIC Launches 'Guowei No.1' Dividend Increasing Whole Life Insurance

CPIC Releases White Paper on Home-based Elder Care

CPIC Launches 'TaiPing LeXiangJu' Home-based Elder Care Platform

Goldman Sachs Raises China 太平 2026 Net Profit Forecast

CPIC Reports Q1 2026 Financial Results

JPMorgan Reports Positive Outlook on China 太平's Stock and Earnings

China 太平 Insurance Holdings Releases 2025 ESG and CSR Report

China 太平 Insurance Holdings Profit Growth 220.9% in 2025

CMBI Raises Target Price for China 太平 to HKD26.5 and Maintains 'Buy' Rating

Citibank 下调 China 太平目标价至 24.5 元

Morgan Stanley Raises China 太平's Profit Forecast, Cuts New Business Value Forecast

CPIC's Profits Soar in 2025 with Key Financial Metrics Showing Positive Growth

CPIC Life Insurance Granted Approval to Add Group Long-term Health Insurance Business

Efficacy of Dividend Insurance Transformation by China 太平 Life in 2025 Annual Performance Release

Chief Executive of China 太平 Outlines Commitment to High-Quality Development Strategy

CHINA TAIPING released FY2025 9 Months Earnings on March 25 (BJT), Actual Revenue: HKD 96.01 B, Actual EPS: HKD 4.497

CHINA TAIPING released FY2025 Q3 earnings on March 25, 2026 (BJT), with actual revenue of HKD 36.87 B and EPS of HKD 2.7535

China 太平 Announces 2025 Annual Report with Total Assets Exceeding 1.9 Trillion HKD

China 太平 Insurance Holdings Reports Significant Profit Growth in 2025 Fiscal Year

CHINA TAIPING released FY2025 earnings on March 25 During-Market (BJT), actual revenue HKD 132.89 B (forecast HKD 260.05 B), actual EPS HKD 7.2509 (forecast HKD 7.4186)

RADIANCE HLDGS

ANCHORSTONE

RIVERINE CHINA

REACH NEW HLDGS

FINELAND LIVING

NUR HOLDINGS

GOLDEN LEAF INT

UBOT HOLDING

MAN YUE TECH

00966

J.P. Morgan analyst maintained a Buy rating on China Taiping Insurance Holdings Co on April 28 and set a price target of HK$30.00. The company’s shares closed last Thursday at HK$21.14.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks China Taiping Insurance Holdings Co has an analyst consensus of Strong Buy, with a price target consensus of HK$28.60.

Tip Ranks

CHINA TAIPING

JPMorgan Chase

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

J.P. Morgan Keeps Their Buy Rating on China Taiping Insurance Holdings Co (CINSF)

CHINA TAIPINGshares rose by 4.26% to HKD22.04, with a trading volume of 3.55 million shares. Despite underperforming the market by 2.8% since its FY25 results, JPMorgan maintains an Overweight rating and a target price of HKD30, highlighting the company's strong participating policy mix and declining funding costs.

AASTOCKS News

CHINA TAIPING Soars 4%+; JPM Keeps Overweight Rating Unchanged

02601

601601

BOCOM International has raised its target price for China Taipingto HKD26.5, reflecting a significant 220.9% year-on-year increase in net profit attributable to shareholders for 2025. The firm anticipates steady growth in the insurance business, with the value of new business projected to reach HKD10.6 billion in 2026. The broker maintains a Buy rating, citing improvements in operational quality and efficiency, alongside a decline in the combined ratio from 98.8% in 2025 to around 98.2% in 2026. The company's share price has risen approximately 14% since 2026.

CPIC

BOCOM INTL

BOCOM International Raises China Taiping  TP to HKD26.5; Explosive Growth in Last Year Results

China Taiping Insurance Holdings Co has updated its board composition, detailing the roles of its executive, non-executive, and independent directors. Mr. Yin Zhaojun chairs the board, with Mr. Li Kedong as vice chairman and general manager. The company clarified the membership and chairmanship of its four key board committees: Audit, Nomination and Remuneration, Risk Management, and Strategy and Investment. This move enhances governance transparency and signals a focus on structured oversight. The latest analyst rating for the stock (HK:0966) is a Buy with a price target of HK$25.00.

China Taiping Clarifies Board Line-Up and Committee Roles

Morgan Stanley lowered the target price for CHINA TAIPING to 25.7 yuan, maintaining a "market perform" rating. Despite strong profit growth and increased dividends in the fiscal year 2025, the growth of new business value in 2026 may lag behind peers, and investors have concerns about the balance sheet. The management has recorded impairment losses of over 30 billion yuan since 2020. The bank raised its forecast for shareholders' attributable net profit for this year and next year by 4% and 3.7%, respectively, but lowered the forecast for new business value by 5% and 2%

AASTOCKS

Morgan Stanley

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Morgan Stanley lowers the target price for CHINA TAIPING to 25.7 yuan, maintaining a "Market Perform" rating

512000

513750

512880

512070

510650

159842

China Taiping's net profit last year surged by 220.9% to 27.059 billion yuan, stimulating the stock price to open 5.29% higher today, currently reported at 22.6 yuan, up 6.7%. Insurance service revenue increased by 9% year-on-year to 24 billion yuan, with a profit growth of 229.2% in the life insurance business. Earnings per share are 7.251 yuan, with a final dividend of 1.23 yuan

Hwabao WP CSI All Share Investment Banking & Brokerage ETF

GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF

Guotai CSI All Share Investment Banking & Brokerage ETF

E Fund CSI 300 Financials (ex Banks) ETF

ChinaAMC SSE Financials Sector ETF Initiating Fund

Yinhua CSI All Share Investment Banking & Brokerage ETF

China Taiping initially rose 6.7%, earning 2.2 times more than last year

601318

02318

China Taiping caps five-year plan with record profits and expanded strategic footprint

Ping An

PING AN

China Taiping caps five-year plan with record profits and expanded strategic footprint

06030

01428

000776

02015

01211

01776

Hong Kong stocks rose in the morning session, with the Hang Seng Index up 254 points at 26,088 points. Insurance, brokerage, and automotive stocks generally increased, with CHINA TAIPING rising 3.8%, GF SECURITIES and CITIC SEC up 5.3% and 7.1% respectively. BRIGHT SMART surged 66% due to news of Ant Group's stake acquisition. Automotive stocks rose on market expectations of price increases in industry competition, with BYD up 2%, and Li Auto and Nio up 3.1%. Battery stock CATL fell 2.4% in the morning session

CITIC SEC

BRIGHT SMART

GF SECURITIES

LI AUTO-W

BYD COMPANY

GF SEC

"Hong Kong Stocks" Hang Seng Index rises 254 points in half a day, with insurance, brokerage, automotive, and pharmaceutical stocks up; Bright Smart resumes trading and surges 66%

Western Securities has maintained a Buy rating on China Taiping Insurance Holdings Co (CINSF) as of March 10, with a price target of HK$31.80. The shares closed at HK$21.78 last Monday. The overall analyst consensus for the company is a Strong Buy, with an average price target of HK$29.35.

China Taiping Insurance Holdings Co (CINSF) Receives a Buy from Western Securities

The Hang Seng Index opened higher, refreshing its nearly four-year high; Tencent's performance exceeded expectations, receiving collective bullish calls from major banks; Chip stocks strengthened on the logic of domestic substitution, with SMIC leading the gains; Ping An's stake increase in China Taiping H-shares ignited the insurance sector; Cryptocurrency concept stocks surged as Bitcoin hit a new high; In the pharmaceutical sector, Jingtai Holdings reported its first profit, rising over 11%, while East Buy saw a sudden 12% increase.

Tencent

TENCENT

TENCENT-R

Tencent HK SDR 10to1

Tencent Holdings Limited

Ping An Insurance

PING AN-R

Ping An Ins HK SDR2to1

SMIC

SMIC HK SDR 5to1

SUNSHINE INS

Life and Health Insurance

REMEGEN

RemeGen

WUXI BIO

WuXi Biologics

BEONE MEDICINES

BeOne Medicines

Beigene

FI2 CSOP HSI

HUA HONG SEMI

Hua Hong

INNOCARE

InnoCare Pharma

GRANDSHORES

AKESO

HORIZONROBOT-W

ZA ONLINE

BITFIRE GROUP

GUOTAI JUNAN I

XTALPI

Life Sciences Tools and Services

XL2CSOPHSTECH

Semiconductors

FL2 CSOP HSI

LINEKONG

INNOVENT BIO

OKG TECH

Interactive Media and Services

CSOP HS TECH

XI2CSOPHSTECH

EAST BUY

Hot Trades in Hong Kong Stocks (8.14) | Hang Seng Index Hits Four-Year High at Opening, Morgan Stanley Says Foreign Capital Accelerated Inflows into Chinese Stock Market in July

MB-CTIH@EC2611A(29208.HK)

J.P. Morgan Keeps Their Buy Rating on China Taiping Insurance Holdings Co (CINSF)

CHINA TAIPING Soars 4%+; JPM Keeps Overweight Rating Unchanged

BOCOM International Raises China Taiping TP to HKD26.5; Explosive Growth in Last Year Results

China Taiping Clarifies Board Line-Up and Committee Roles

Morgan Stanley lowers the target price for CHINA TAIPING to 25.7 yuan, maintaining a "Market Perform" rating